U.S. Markets open in 5 mins

Top Ranked Value Stocks to Buy for July 31st

Zacks Equity Research

Here are four stocks with buy rank and strong value characteristics for investors to consider today, July 31st:

Radian Group Inc. (RDN): This provider of mortgage insurance as well as a range of mortgage, risk, real estate and title services has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 0.7% over the last 60 days.

Radian Group Inc. Price and Consensus

Radian Group Inc. Price and Consensus

Radian Group Inc. price-consensus-chart | Radian Group Inc. Quote

Radian has a price-to-earnings ratio (P/E) of 8.22 compared with 14.90 for the industry. The company possesses a Value Score of B.

Radian Group Inc. PE Ratio (TTM)

Radian Group Inc. PE Ratio (TTM)

Radian Group Inc. pe-ratio-ttm | Radian Group Inc. Quote

Mr. Cooper Group Inc. (COOP): This provider of quality servicing, origination as well as transaction-based services related to single-family residences has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 3.3% over the last 60 days.

MR. COOPER GROUP INC Price and Consensus

MR. COOPER GROUP INC Price and Consensus

MR. COOPER GROUP INC price-consensus-chart | MR. COOPER GROUP INC Quote

Mr. Cooper Group has a price-to-earnings ratio (P/E) of 4.93 compared with 8.70 for the industry. The company possesses a Value Score of B.

MR. COOPER GROUP INC PE Ratio (TTM)

MR. COOPER GROUP INC PE Ratio (TTM)

MR. COOPER GROUP INC pe-ratio-ttm | MR. COOPER GROUP INC Quote

Health Insurance Innovations, Inc. (HIIQ): This cloud-based technology platform has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 11.4% over the last 60 days.

Health Insurance Innovations, Inc. Price and Consensus

Health Insurance Innovations, Inc. Price and Consensus

Health Insurance Innovations, Inc. price-consensus-chart | Health Insurance Innovations, Inc. Quote

Health Insurance Innovations has a price-to-earnings ratio (P/E) of 5.92 compared with 7.80 for the industry. The company possesses a Value Score of B.

Health Insurance Innovations, Inc. PE Ratio (TTM)

Health Insurance Innovations, Inc. PE Ratio (TTM)

Health Insurance Innovations, Inc. pe-ratio-ttm | Health Insurance Innovations, Inc. Quote

Cleveland-Cliffs Inc. (CLF): This producer of iron ore pellets in North America has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 6.5% over the last 60 days.

Cleveland-Cliffs Inc. Price and Consensus

Cleveland-Cliffs Inc. Price and Consensus

Cleveland-Cliffs Inc. price-consensus-chart | Cleveland-Cliffs Inc. Quote

Cleveland-Cliffs has a price-to-earnings ratio (P/E) of 6.20 compared with 8.50 for the industry. The company possesses a Value Score of A.

Cleveland-Cliffs Inc. PE Ratio (TTM)

Cleveland-Cliffs Inc. PE Ratio (TTM)

Cleveland-Cliffs Inc. pe-ratio-ttm | Cleveland-Cliffs Inc. Quote

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Radian Group Inc. (RDN) : Free Stock Analysis Report
 
Health Insurance Innovations, Inc. (HIIQ) : Free Stock Analysis Report
 
MR. COOPER GROUP INC (COOP) : Free Stock Analysis Report
 
Cleveland-Cliffs Inc. (CLF) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research